Breaking News Instant updates and real-time market news.

ALLO

Allogene Therapeutics

$31.08

0.84 (2.78%)

07:36
05/07/19
05/07
07:36
05/07/19
07:36

Allogene Therapeutics reports Q1 EPS (32c), consensus (43c)

"We are very pleased with our ability to accelerate the research and development activities for both ALLO-501 and ALLO-715," said David Chang, M.D., Ph.D., President, CEO and Co-Founder of Allogene. "Our focus from day one has been on the acceleration of AlloCAR T therapy to enable an "off-the-shelf" CAR T therapy for patients. In May 2018, we started Allogene with approximately 40 employees. Today, we have over 150 employees, all dedicated to making AlloCAR T therapy a reality." An Investigational New Drug application has been submitted to the U.S. FDA for ALLO-715, a wholly-owned CAR T product candidate targeting B cell maturation antigen for relapsed/refractory multiple myeloma. The Company remains on track to initiate a Phase 1 trial in 2019.

  • 07

    May

  • 06

    Jun

ALLO Allogene Therapeutics
$31.08

0.84 (2.78%)

03/29/19
PIPR
03/29/19
INITIATION
Target $50
PIPR
Overweight
Allogene Therapeutics initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Tyler Van Buren started Allogene Therapeutics with an Overweight rating and $50 price target. The company is well positioned to deliver on the promises of allogeneic CAR-T therapy given the prior success of its "world-class" management team in the autologous setting and the initial strategy to pursue de-risked targets, Van Buren tells investors in a research note. He calls the initial efficacy data from UCART19 "competitive" and is optimistic about the ability for an anti-CD52-containing lymphodepletion regimen to "meaningfully increase" donor CAR-T cell expansion.
04/29/19
PIPR
04/29/19
NO CHANGE
Target $50
PIPR
Overweight
Allogene best positioned among next gen cell therapies, says Piper Jaffray
After conducting nearly 30 hours' worth of interviews with C-level management at numerous companies, Piper Jaffray analyst Tyler Van Buren says Allogene Therapeutics is best positioned among the wave of next generation cell therapies. Allogene is implementing changes on a "methodical, step-by-step basis that could enable a higher quality and more homogenous product," Van Buren tells investors in a research note. He keeps an Overweight rating on the shares with a $50 price target.
05/02/19
OPCO
05/02/19
INITIATION
Target $45
OPCO
Outperform
Allogene Therapeutics initiated with an Outperform at Oppenheimer
Oppenheimer analyst Mark Breidenbach started Allogene Therapeutics with an Outperform rating and $45 price target.
05/02/19
OPCO
05/02/19
INITIATION
Target $45
OPCO
Outperform
Oppenheimer starts Allogene with Outperform rating, $45 price target
Oppenheimer analyst Mark Breidenbach initiated coverage of Allogene Therapeutics with an Outperform rating and $45 price target. The company is developing allogeneic products which could address "significant" issues surrounding today's autologous CARTs including manufacturing bandwidth, cost and consistency, Breidenbach tells investors in a research note. He believes Allogene has the wherewithal to make off-the-shelf CAR-Ts a "commercial reality" and points out it has "multiple de-risking data readouts" over the next 12-18 months.

TODAY'S FREE FLY STORIES

LTXB

LegacyTexas Financial

$39.02

0.11 (0.28%)

18:36
06/18/19
06/18
18:36
06/18/19
18:36
Downgrade
LegacyTexas Financial rating change  »

LegacyTexas Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

UNP

Union Pacific

$165.49

0.885 (0.54%)

18:24
06/18/19
06/18
18:24
06/18/19
18:24
Hot Stocks
Union Pacific CEO: The President is addressing the right topics with China »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

MYOS

MYOS

$1.40

0.11 (8.53%)

18:12
06/18/19
06/18
18:12
06/18/19
18:12
Hot Stocks
MYOS says fortetropin shows increase rate of muscle protein synthesis in study »

MYOS RENS Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$36.71

0.58 (1.61%)

18:06
06/18/19
06/18
18:06
06/18/19
18:06
Periodicals
Breaking Periodicals news story on General Motors »

GM, UAW negotiating to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 12

    Aug

BXC

BlueLinx

$22.03

0.305 (1.40%)

18:00
06/18/19
06/18
18:00
06/18/19
18:00
Hot Stocks
BlueLinx sells two distribution facilities for $12M »

BlueLinx Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$0.00

(0.00%)

, BA

Boeing

$374.21

19.31 (5.44%)

17:59
06/18/19
06/18
17:59
06/18/19
17:59
Periodicals
U.S. expected to be open to ending aircraft subsidy dispute, Reuters says »

The U.S. is expected to…

EADSY

Airbus

$0.00

(0.00%)

BA

Boeing

$374.21

19.31 (5.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

FB

Facebook

$188.46

-0.43 (-0.23%)

17:56
06/18/19
06/18
17:56
06/18/19
17:56
Periodicals
House Banking chair Waters calls on Facebook to halt Libra, Reuters says »

House Financial Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

OII

Oceaneering

$18.34

0.7 (3.97%)

, APC

Anadarko

$69.95

0.16 (0.23%)

17:36
06/18/19
06/18
17:36
06/18/19
17:36
Hot Stocks
Oceaneering awarded supply contract for Mozambique LNG Project »

Oceaneering (OII)…

OII

Oceaneering

$18.34

0.7 (3.97%)

APC

Anadarko

$69.95

0.16 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

GVA

Granite Construction

$44.64

1.335 (3.08%)

17:35
06/18/19
06/18
17:35
06/18/19
17:35
Hot Stocks
Granite Construction JV awarded $275M highway construction project in Sacremento »

Granite Construction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$69.95

0.16 (0.23%)

, FTI

TechnipFMC

$23.76

0.7 (3.04%)

17:33
06/18/19
06/18
17:33
06/18/19
17:33
Hot Stocks
TechnipFMC awarded subsea contracts by subsidiary of Anadarko Petroleum »

TechnipFMC (FTI) has been…

APC

Anadarko

$69.95

0.16 (0.23%)

FTI

TechnipFMC

$23.76

0.7 (3.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 25

    Jul

MDT

Medtronic

$97.96

0.65 (0.67%)

17:33
06/18/19
06/18
17:33
06/18/19
17:33
Hot Stocks
Medtronic exec Surface sells 9,000 ordinary shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

EAF

GrafTech

$10.95

0.14 (1.30%)

17:20
06/18/19
06/18
17:20
06/18/19
17:20
Syndicate
Breaking Syndicate news story on GrafTech »

GrafTech files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$69.95

0.16 (0.23%)

17:12
06/18/19
06/18
17:12
06/18/19
17:12
Hot Stocks
Anadarko Area 1 Plan of Development now effective »

Anadarko Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMASY

Inmarsat

$0.00

(0.00%)

17:11
06/18/19
06/18
17:11
06/18/19
17:11
Hot Stocks
Inmarsat awarded $246M Defense Information Systems Agency BPA »

Inmarsat has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLX

Deluxe

$41.32

-0.505 (-1.21%)

17:03
06/18/19
06/18
17:03
06/18/19
17:03
Hot Stocks
Deluxe appoints Chief Strategy Officer, Chief Human Resources Officer »

Deluxe Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFIE

Profire Energy

$1.40

0.03 (2.19%)

17:02
06/18/19
06/18
17:02
06/18/19
17:02
Hot Stocks
Profire Energy subsidiary to acquire assets of Millstream Energy Products »

Profire Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$14.59

0.29 (2.03%)

, GOOG

Alphabet

$1,104.40

12.15 (1.11%)

17:02
06/18/19
06/18
17:02
06/18/19
17:02
Hot Stocks
HP Enterprise, Google Cloud expand strategic partnership »

HP Enterprise (HPE) and…

HPE

HP Enterprise

$14.59

0.29 (2.03%)

GOOG

Alphabet

$1,104.40

12.15 (1.11%)

GOOGL

Alphabet Class A

$1,105.22

12.51 (1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

  • 09

    Jul

  • 10

    Jul

  • 27

    Oct

HPE

HP Enterprise

$14.59

0.29 (2.03%)

17:01
06/18/19
06/18
17:01
06/18/19
17:01
Hot Stocks
HP Enterprise to transition into an as a Service company by 2022 »

Hewlett Packard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

MTSI

Macom

$14.40

-0.02 (-0.14%)

16:55
06/18/19
06/18
16:55
06/18/19
16:55
Hot Stocks
Breaking Hot Stocks news story on Macom »

Macom falls 13% to $12.50…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTSI

Macom

$14.40

-0.02 (-0.14%)

16:53
06/18/19
06/18
16:53
06/18/19
16:53
Hot Stocks
Macom to lay off 20% of staff or 250 workers, expects $50M in savings »

MACOM announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRRK

Scholar Rock

$19.95

1.265 (6.77%)

16:52
06/18/19
06/18
16:52
06/18/19
16:52
Syndicate
Scholar Rock files to sell 3M shares of common stock »

Jefferies, Cowen and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTSI

Macom

$14.40

-0.02 (-0.14%)

16:50
06/18/19
06/18
16:50
06/18/19
16:50
Earnings
Macom cuts Q3 EPS view to (45c) to (41c) from (8c) to (4c), consensus (6c) »

Cuts Q3 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTSI

Macom

$14.40

-0.02 (-0.14%)

16:48
06/18/19
06/18
16:48
06/18/19
16:48
Earnings
Breaking Earnings news story on Macom »

Macom cuts Q3 EPS,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTFT

Future FinTech

$1.18

0.04 (3.51%)

16:48
06/18/19
06/18
16:48
06/18/19
16:48
Hot Stocks
Future FinTech submits compliance plan to Nasdaq »

Future FinTech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PKOH

Park-Ohio

$32.11

-0.08 (-0.25%)

16:45
06/18/19
06/18
16:45
06/18/19
16:45
Hot Stocks
ParkOhio's Edward Crawford resigns as officer, board member »

ParkOhio announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.